Stealth BioTherapeutics (Stealth BioTherapeutics) Gross-Profit-to-Asset % : 0.00% (As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Stealth BioTherapeutics's annualized Gross Profit for the quarter that ended in Mar. 2022 was $0.00 Mil. Stealth BioTherapeutics's average Total Assets over the quarter that ended in Mar. 2022 was $43.57 Mil. Therefore, Stealth BioTherapeutics's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2022 was 0.00%.

Stealth BioTherapeutics Gross-Profit-to-Asset % Historical Data

The historical data trend for Stealth BioTherapeutics's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics Gross-Profit-to-Asset % Chart

Stealth BioTherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

61.78

Stealth BioTherapeutics Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Stealth BioTherapeutics's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Stealth BioTherapeutics's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stealth BioTherapeutics's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stealth BioTherapeutics's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Stealth BioTherapeutics's Gross-Profit-to-Asset % falls into.

Stealth BioTherapeutics Gross-Profit-to-Asset % Calculation

Stealth BioTherapeutics's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2021 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2021 )	/	( (Total Assets (A: Dec. 2020 )	+	Total Assets (A: Dec. 2021 ))	/ count )
	=	0	/	( (35.848	+	50.226)	/ 2 )
	=	0	/	43.037
	=	0.00 %

Stealth BioTherapeutics's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2022 )	/	( (Total Assets (Q: Dec. 2021 )	+	Total Assets (Q: Mar. 2022 ))	/ count )
	=	0	/	( (50.226	+	36.915)	/ 2 )
	=	0	/	43.5705
	=	0.00 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2022) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Stealth BioTherapeutics Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Stealth BioTherapeutics's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005

Website

https://www.stealthbt.com

Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.